Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 88.18B | 81.97B | 94.82B | 91.17B | 90.80B | 78.36B |
Gross Profit | 32.69B | 30.46B | 35.15B | 34.19B | 35.28B | 30.50B |
EBITDA | 15.69B | 14.62B | 40.58B | 16.07B | 16.41B | 13.79B |
Net Income | 1.22B | 4.32B | 28.85B | 4.20B | 5.12B | -11.00B |
Balance Sheet | ||||||
Total Assets | 480.03B | 476.56B | 447.75B | 434.77B | 436.32B | 433.11B |
Cash, Cash Equivalents and Short-Term Investments | 26.84B | 21.03B | 14.08B | 11.61B | 22.89B | 29.26B |
Total Debt | 103.84B | 96.61B | 74.90B | 73.29B | 66.89B | 73.32B |
Total Liabilities | 165.94B | 157.89B | 122.98B | 118.83B | 112.15B | 113.96B |
Stockholders Equity | 257.88B | 258.30B | 268.13B | 258.46B | 266.95B | 262.69B |
Cash Flow | ||||||
Free Cash Flow | 8.25B | 5.89B | 6.32B | 4.73B | 7.45B | 8.46B |
Operating Cash Flow | 13.39B | 10.46B | 9.92B | 8.16B | 11.66B | 11.46B |
Investing Cash Flow | -9.40B | -14.60B | 13.03B | -17.54B | -6.34B | 1.73B |
Financing Cash Flow | 5.02B | 12.62B | -21.73B | -1.40B | -12.34B | -5.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $7.90B | 37.27 | 14.51% | 0.66% | -0.15% | 24.55% | |
74 Outperform | $132.69B | 23.77 | 34.60% | 2.16% | 7.16% | 0.21% | |
71 Outperform | $10.62B | 69.71 | 0.47% | 5.34% | 6.84% | -95.35% | |
65 Neutral | $3.57B | 57.14 | 48.69% | 0.94% | -3.37% | -61.83% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | $83.05B | 22.07 | 96.00% | 1.86% | -19.56% | 325.26% | |
52 Neutral | $4.73B | ― | -21.56% | 23.95% | -11.23% | -6.85% |